He's most cautious about the shares of Aurora and Tilray, seeing them as dependent on international opportunities for medical marijuana—which ...
Marijuana Stocks Analyst Says Only Canopy Growth Is Worth Buying
- Written by: Norris Garman
- Category: Drug News
- Hits: 800